Hutch News

Early clinical trial highlights cancer vaccines as potential affordable, safe and effective breast cancer treatment

Early clinical trial highlights cancer vaccines as potential affordable, safe and effective breast cancer treatment

From the Cancer Vaccine Institute, University of Washington, and the Cancer Consortium Breast & Ovary Cancers Program
Science SpotlightJuly 17, 2023
Un ensayo clínico inicial destaca las vacunas contra el cáncer como posible tratamiento asequible, seguro y eficaz contra el cáncer de mama

Un ensayo clínico inicial destaca las vacunas contra el cáncer como posible tratamiento asequible, seguro y eficaz contra el cáncer de mama

Del Cancer Vaccine Institute [Instituto de Vacunas contra el Cáncer], la Universidad de Washington y del Cancer Consortium Breast & Ovary Cancers Program [Programa de Cáncer de Mama y Ovario del Consorcio del Cáncer].
Science SpotlightJuly 17, 2023
Improving cancer vaccines with T-cell programming nanoparticles

Improving cancer vaccines with T-cell programming nanoparticles

Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology
Hutch NewsJuly 31, 2018
Teacher, mom — and living immunotherapy proof of principle

Teacher, mom — and living immunotherapy proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.
Hutch NewsSeptember 08, 2017